Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Genomic Health Inc (GHDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,895,862
  • Shares Outstanding, K 37,072
  • Annual Sales, $ 394,110 K
  • Annual Income, $ 25,680 K
  • 60-Month Beta 1.05
  • Price/Sales 4.93
  • Price/Cash Flow 36.16
  • Price/Book 6.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.35
  • Number of Estimates 6
  • High Estimate 0.40
  • Low Estimate 0.32
  • Prior Year 0.26
  • Growth Rate Est. (year over year) +34.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.77 +2.62%
on 06/12/19
57.44 -9.29%
on 05/21/19
-2.08 (-3.84%)
since 05/17/19
3-Month
50.77 +2.62%
on 06/12/19
75.52 -31.01%
on 03/21/19
-22.40 (-30.07%)
since 03/15/19
52-Week
48.66 +7.07%
on 06/18/18
92.18 -43.48%
on 11/07/18
+2.51 (+5.06%)
since 06/15/18

Most Recent Stories

More News
Genomic Health I Shares Down 30.3% Since SmarTrend's Sell Call (GHDX)

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on March 6th, 2019 at $75.16. In approximately 3 months, Genomic Health I has returned 30.30% as of today's recent price of $52.39.

GHDX : 52.28 (+2.23%)
Why Is Genomic Health (GHDX) Down 5% Since Last Earnings Report?

Genomic Health (GHDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GHDX : 52.28 (+2.23%)
Genomic Health I Down 27.2% Since SmarTrend Downtrend Call (GHDX)

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on March 6th, 2019 at $75.16. In approximately 3 months, Genomic Health I has returned 27.18% as of today's recent price of $54.73.

GHDX : 52.28 (+2.23%)
Secondary Analysis of Landmark TAILORx Results, Published in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® Test to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision

- Additional detail in patients age 50 or younger presented in oral session at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

GHDX : 52.28 (+2.23%)
Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision

Additional Detail in Patients Age 50 or Younger Presented Today in Oral Session at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

GHDX : 52.28 (+2.23%)
Updated ASCO Guidelines Establish TAILORx-defined Cutoffs for Determining Chemotherapy Benefit with the Oncotype DX Breast Recurrence Score® Test in Node-negative Breast Cancer

New ASCO Recommendations Increase Proportion of Women Who Can Be Spared Chemotherapy Based on Landmark TAILORx and NSABP B-20 Randomized Clinical Trials

GHDX : 52.28 (+2.23%)
Genomic Health I Falls 2.19% on Heavy Volume: Watch For Potential Rebound

Genomic Health I (NASDAQ:GHDX) traded in a range yesterday that spanned from a low of $55.00 to a high of $55.92. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of...

GHDX : 52.28 (+2.23%)
Genomic Health I Has Returned 22.1% Since SmarTrend Recommendation (GHDX)

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on March 6th, 2019 at $75.16. In approximately 2 months, Genomic Health I has returned 22.13% as of today's recent price of $58.53.

GHDX : 52.28 (+2.23%)
Look for Shares of Genomic Health I to Potentially Rebound after Yesterday's 11.84% Sell Off

Genomic Health I (NASDAQ:GHDX) traded in a range yesterday that spanned from a low of $57.71 to a high of $58.74. Yesterday, the shares fell 11.8%, which took the trading range below the 3-day low of...

GHDX : 52.28 (+2.23%)
Genomic Health (GHDX) Q1 Earnings Top Estimates, Margins Up

Genomic Health (GHDX) registers strong year-over-year growth in revenues on solid domestic and overseas performances.

SYK : 196.50 (+0.53%)
GHDX : 52.28 (+2.23%)
XRAY : 56.74 (-0.05%)
CNMD : 83.05 (+0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade GHDX with:

Business Summary

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict...

See More

Key Turning Points

2nd Resistance Point 52.97
1st Resistance Point 52.05
Last Price 52.28
1st Support Level 50.67
2nd Support Level 50.21

See More

52-Week High 92.18
Fibonacci 61.8% 75.56
Fibonacci 50% 70.42
Fibonacci 38.2% 65.28
Last Price 52.28
52-Week Low 48.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar